AG
Artal Group’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-494,421
| Closed | -$26.8M | – | 23 |
|
|
2024
Q2 | $26.8M | Sell |
494,421
-12,163
| -2% | -$659K | 0.68% | 18 |
|
|
2024
Q1 | $35.5M | Sell |
506,584
-707,700
| -58% | -$49.6M | 0.9% | 17 |
|
|
2023
Q4 | $101M | Sell |
1,214,284
-304,547
| -20% | -$25.4M | 3.37% | 4 |
|
|
2023
Q3 | $44.7M | Buy |
1,518,831
+102,800
| +7% | +$3.03M | 1.92% | 10 |
|
|
2023
Q2 | $46.2M | Buy |
1,416,031
+49,008
| +4% | +$1.6M | 1.43% | 12 |
|
|
2023
Q1 | $48.1M | Buy |
1,367,023
+367,023
| +37% | +$12.9M | 2.86% | 9 |
|
|
2022
Q4 | $45.8M | Hold |
1,000,000
| – | – | 2.56% | 12 |
|
|
2022
Q3 | $48.5M | Sell |
1,000,000
-275,000
| -22% | -$13.3M | 2.07% | 14 |
|
|
2022
Q2 | $50.1M | Buy |
1,275,000
+275,000
| +28% | +$10.8M | 2.68% | 10 |
|
|
2022
Q1 | $36.8M | Hold |
1,000,000
| – | – | 1.54% | 17 |
|
|
2021
Q4 | $45.6M | Sell |
1,000,000
-300,000
| -23% | -$13.7M | 1.24% | 19 |
|
|
2021
Q3 | $46.5M | Buy |
1,300,000
+800,000
| +160% | +$28.6M | 1.04% | 21 |
|
|
2021
Q2 | $9.9M | Buy |
+500,000
| New | +$9.9M | 0.2% | 83 |
|
|
2021
Q1 | – | Sell |
-500,000
| Closed | -$10.4M | – | 146 |
|
|
2020
Q4 | $10.4M | Buy |
+500,000
| New | +$10.4M | 0.22% | 80 |
|